Johannes Gutenberg University of Mainz-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)

    Lung Cancer, Vol. 120, pp. 27-33